China National Medicines Corporation Ltd.

Shanghai Stock Exchange:600511.SS

Sector

🏥 Health Care

Industries

💊 Drugstores & Retail Pharmacies

🩺 Medical Instruments

💊 Pharmaceuticals

Location

China

Market Cap

USD 3.12 B

Share Price

USD 4.14

Avg Daily Volume

4,127,056

Change (1 day)

0.27%

Change (1 year)

-11.05%

Change (YTD)

-11.70%

China National Medicines Corporation Ltd. Research and Development (R&D) Expenses for the year ending December 31, 2024: USD 10.10 M

China National Medicines Corporation Ltd. Research and Development (R&D) Expenses is USD 10.10 M for the year ending December 31, 2024, a 0.67% change year over year. Research and development (R&D) expenses are the costs associated with the development of new products, technologies, or improvements to existing products.

China National Medicines Corporation Ltd. Research and Development (R&D) Expenses for the year ending December 31, 2023 was USD 10.03 M, a 3.29% change year over year.
China National Medicines Corporation Ltd. Research and Development (R&D) Expenses for the year ending December 31, 2022 was USD 9.71 M, a 10.65% change year over year.
China National Medicines Corporation Ltd. Research and Development (R&D) Expenses for the year ending December 31, 2021 was USD 8.77 M, a 10.41% change year over year.
China National Medicines Corporation Ltd. Research and Development (R&D) Expenses for the year ending December 31, 2020 was USD 7.95 M, a 23.17% change year over year.